Pimobendan oral solution is bioequivalent to pimobendan chewable tablets in beagle dogs
Abstract Background Myxomatous mitral valve disease (MMVD) is frequently diagnosed in small breed dogs. Pimobendan oral solution has been developed to improve dosing accuracy in small and toy breed dogs. Hypothesis/Objectives Demonstrate bioequivalence of pimobendan oral solution with pimobendan che...
Saved in:
Main Authors: | Olaf Kuhlmann, Michael Markert |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Journal of Veterinary Internal Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1111/jvim.17248 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics and Bioequivalence of Two Fixed-Dose Combination Tablets of Valsartan/Amlodipine (80/5 Mg) in Healthy Chinese Subjects
by: Tian M, et al.
Published: (2025-01-01) -
Comparative study on the bioavailability and bioequivalence of rifapentine capsules in humans
by: Ying Qi, et al.
Published: (2025-01-01) -
Evaluating the pharmacokinetics and safety of blonanserin tablets and Lonasen®: a randomized, open-label, two-period, two-sequence, self-crossover phase I clinical trial
by: Bo Qiu, et al.
Published: (2025-01-01) -
Pharmacokinetic comparisons of S-oxiracetam and R-oxiracetam in beagle dogs
by: Wang Wusan, et al.
Published: (2016-06-01) -
A multicenter, randomized, open label, two formulation, crossover bioequivalence trial of doxorubicin hydrochloride liposomal injection in Chinese patients with metastatic breast cancer
by: Jingshu Wang, et al.
Published: (2025-01-01)